{"gene":"RBP4","run_date":"2026-04-28T19:45:45","timeline":{"discoveries":[{"year":2012,"finding":"RBPR2, a novel retinol transporter structurally related to STRA6, was identified as the liver and intestinal receptor for RBP4. Expression of RBPR2 in cultured cells confers high-affinity RBP4 binding and retinol transport, and RBPR2 knockdown reduces RBP4 binding and retinol transport.","method":"Cell transfection, receptor binding assay, knockdown, in vitro retinol transport assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — functional reconstitution in cells plus knockdown with direct transport readout, single paper with multiple orthogonal methods","pmids":["23105095"],"is_preprint":false},{"year":2018,"finding":"Human plasma RBP4 binds fatty acids (palmitic and lauric acid) in its hydrophobic ligand-binding pocket in addition to retinol, as determined by high-resolution crystal structures confirmed by mass spectrometry.","method":"X-ray crystallography (1.5 Å resolution), mass spectrometry","journal":"Biochimica et biophysica acta. Molecular and cell biology of lipids","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with orthogonal MS confirmation, multiple crystal forms (plasma, urine, amniotic fluid)","pmids":["29414511"],"is_preprint":false},{"year":2014,"finding":"RBP4 causes adipose tissue inflammation and systemic insulin resistance by directly activating antigen-presenting cells (APCs) through a JNK-dependent pathway, which then elicits CD4 T cell Th1 polarization. Transfer of RBP4-activated APCs into normal mice is sufficient to induce AT inflammation and insulin resistance.","method":"RBP4-overexpressing transgenic mice, adoptive transfer of APCs, JNK pathway inhibition, glucose/insulin tolerance tests","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — epistasis via adoptive transfer, pathway inhibition, multiple in vivo readouts; replicated mechanistically in follow-up study (PMID:26936962)","pmids":["24606904"],"is_preprint":false},{"year":2016,"finding":"RBP4-induced macrophage antigen presentation and T-cell activation requires MyD88 and downstream MAPK (JNK, ERK, p38) and NF-κB pathways; in MyD88-deficient macrophages RBP4 fails to stimulate TNF, IL-12, and IL-6 secretion. In vivo blockade of antigen presentation with CTLA4-Ig reduces AT inflammation and improves insulin resistance in RBP4-overexpressing mice.","method":"MyD88 knockout macrophages, pathway inhibitors, CTLA4-Ig in vivo blockade, cytokine measurement, insulin/glucose tolerance tests","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — genetic KO plus pharmacological rescue plus in vivo intervention; multiple orthogonal methods","pmids":["26936962"],"is_preprint":false},{"year":2016,"finding":"Hepatocytes are the principal source of circulating RBP4; liver-specific RBP4 knockout mice have undetectable circulating RBP4 despite intact adipose tissue RBP4 expression and secretion, even in diet-induced insulin resistance.","method":"Hepatocyte-specific Cre-lox RBP4 knockout mice, circulating RBP4 measurement, adipose tissue RBP4 expression analysis","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with definitive source-of-circulating-protein readout; directly falsifies adipocyte origin hypothesis","pmids":["27797907"],"is_preprint":false},{"year":2015,"finding":"Dominant-negative missense mutations in RBP4 greatly reduce retinol binding but paradoxically increase affinity for the cell-surface receptor STRA6, thereby competitively blocking retinol delivery from wild-type RBP4 to fetal and placental tissues and causing ocular malformations.","method":"Missense mutation identification in families, retinol binding assays, STRA6 binding assays, functional characterization of mutant proteins","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical assays of retinol and receptor binding combined with human genetics and maternal transmission analysis; multiple orthogonal approaches","pmids":["25910211"],"is_preprint":false},{"year":2014,"finding":"Circulating transthyretin (TTR) stabilizes RBP4 by preventing its glomerular filtration; antisense oligonucleotide knockdown of TTR reduces circulating RBP4 by 80-95% and improves insulin sensitivity, hepatic glucose production suppression, and muscle glucose uptake in obese mice.","method":"TTR antisense oligonucleotides in ob/ob and HFD mice, hyperinsulinemic-euglycemic clamp, glucose uptake measurement, insulin signaling assays","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — genetic/pharmacological manipulation with quantitative metabolic readouts in multiple mouse models; clamp studies provide definitive insulin sensitivity measurement","pmids":["25524914"],"is_preprint":false},{"year":2017,"finding":"RBP4 activates STRA6 as a cytokine receptor to transduce a JAK2-STAT3 signaling cascade, which promotes cancer stem cell maintenance and tumor initiation in colon cancer; downregulation of STRA6 or RBP4 decreases cancer stem cell fraction and sphere/tumor initiation frequency.","method":"STRA6/RBP4 knockdown in colon cancer cells, sphere formation assay, xenograft mouse model, flow cytometry for cancer stem cells","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — knockdown with multiple cellular and in vivo readouts, single lab","pmids":["28689994"],"is_preprint":false},{"year":2017,"finding":"Retinol-bound (holo-)RBP4 activates STRA6 and downstream JAK2/STAT3 signaling to promote denervation-induced muscle atrophy and fat infiltration; inhibition of STRA6, JAK2, or STAT3 (by siRNA or inhibitors) reduces Atrogin-1 and MuRF1 upregulation and protects myotube diameter. Pharmacological RBP4 antagonist A1120 inhibits this pathway and ameliorates muscle atrophy in vivo.","method":"RBP4 knockout mice, intramuscular injection of holo- vs apo-RBP4, siRNA knockdown of STRA6/JAK2/STAT3, specific pathway inhibitors, C2C12 myotube assays, denervation model, A1120 pharmacological blockade","journal":"Journal of cachexia, sarcopenia and muscle","confidence":"High","confidence_rationale":"Tier 1-2 — genetic KO, reconstitution with recombinant proteins, siRNA pathway dissection, pharmacological rescue; multiple orthogonal methods in one study","pmids":["39031684"],"is_preprint":false},{"year":2017,"finding":"Apo-RBP4 (retinol-free form) functions as a ligand that activates STRA6 and downstream JAK2/STAT5 cascade, leading to SOCS3 upregulation, decreased phosphorylation of IR and IRS1, attenuated GLUT4 translocation, and insulin resistance. Co-immunoprecipitation confirmed prolonged apo-RBP4/STRA6 interaction compared to holo-RBP4.","method":"Co-immunoprecipitation, Western blotting, immunofluorescence, in vivo apo-RBP4 injection in pregnant rats, primary human adipocyte culture","journal":"Archives of gynecology and obstetrics","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus in vivo and in vitro functional validation, single lab","pmids":["28528355"],"is_preprint":false},{"year":2020,"finding":"RBP4 directly stimulates basal lipolysis in human adipocytes in vitro; RBP4-activated macrophages produce TNFα that markedly increases basal lipolysis and impairs insulin-mediated lipolysis suppression in adipocytes.","method":"RBP4 treatment of human adipocytes, conditioned media from RBP4-activated macrophages, lipolysis assays, cytokine measurement","journal":"FASEB journal","confidence":"Medium","confidence_rationale":"Tier 2 — direct in vitro functional assay in human cells with mechanistic dissection, single lab","pmids":["32167208"],"is_preprint":false},{"year":2009,"finding":"HMGA1 is a transcriptional regulator required for basal and cAMP-induced RBP4 gene and protein expression; glucagon (via cAMP) upregulates both HMGA1 and RBP4 in wild-type mice, while Hmga1-knockout mice show severely attenuated RBP4 expression correlated with increased GLUT4 and Akt activation in muscle and fat.","method":"Hmga1-knockout mouse model, glucagon administration, qPCR, Western blotting, GLUT4 and Akt assays in multiple tissues","journal":"BMC biology","confidence":"Medium","confidence_rationale":"Tier 2 — genetic KO with in vivo hormonal challenge and multiple downstream readouts, single lab","pmids":["19460132"],"is_preprint":false},{"year":2013,"finding":"Non-retinoid RBP4 antagonist A1120 binds RBP4 with high affinity and inhibits the RBP4-TTR interaction, reducing serum RBP4 by 75% in mice and correlating with reduction in visual cycle retinoids and ocular lipofuscin bisretinoids, without acting as a RARα agonist unlike fenretinide.","method":"In vitro RBP4 binding assay, RBP4-TTR interaction assay, RPE microsome isomerohydrolase assay, in vivo mouse dosing (Abca4−/− model), biochemical and electrophysiological analysis","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding reconstitution plus in vivo mechanistic validation with multiple biochemical endpoints and receptor specificity characterization","pmids":["23211825"],"is_preprint":false},{"year":2022,"finding":"Exosomal RBP4 from hepatocytes promotes M1-like polarization of Kupffer cells via NOX2/ROS/NF-κB pathway, which then induces TNFα secretion that activates STAT3 in hepatocytes to further upregulate RBP4 transcription, creating a positive feedback loop promoting NAFLD.","method":"Serum exosome characterization, Kupffer cell polarization assays, NOX2/NF-κB inhibition, TNFα treatment of hepatocytes, intravenous RBP4 injection in HFD mice, lipogenesis gene expression","journal":"Free radical biology & medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro pathway dissection plus in vivo reconstitution with recombinant protein, single lab","pmids":["36572267"],"is_preprint":false},{"year":2016,"finding":"Rbp4-deficient mice in the C57BL/6 background accumulate retinol in the liver but have undetectable serum retinol, demonstrating that RBP4 is critical for mobilization of retinol from hepatic storage pools; these mice develop severe ocular phenotypes including photoreceptor degeneration, loss of choroid, and persistent hyaloid artery.","method":"Rbp4-knockout mouse model, electroretinography, histological analysis, retinol quantification in serum and liver","journal":"Laboratory investigation","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with definitive biochemical (retinol mobilization) and structural/functional (ERG, histology) readouts","pmids":["26974396"],"is_preprint":false},{"year":2018,"finding":"A canine RBP4 K12del mutation near the N-terminus disrupts RBP4 folding in vivo, decreasing its secretion from hepatocytes to serum, and causes ocular malformations only when both dam and offspring carry the deletion homozygously, demonstrating recessive maternal inheritance through impaired sequential retinol transfer across the placenta.","method":"Whole genome sequencing, in vivo secretion assays, NMR structural analysis (implied by Permi co-author), maternal-fetal transmission analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 — genetic identification with in vivo functional characterization of secretion defect and mechanistic explanation of maternal inheritance","pmids":["29847795"],"is_preprint":false},{"year":2013,"finding":"IL-1β downregulates RBP4 mRNA expression and secretion in human adipocytes in a time- and dose-dependent manner, mediated through the IL-1 receptor and NF-κB pathway; IL-1 receptor blocking antibody and NF-κB inhibitors reverse this effect.","method":"Human SGBS and primary adipocytes treated with recombinant cytokines and macrophage conditioned media, qPCR, ELISA, IL-1R blocking antibody, NF-κB inhibitors (CAPE, SC-514)","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — receptor blocking and pathway inhibition with multiple human cell models, single lab","pmids":["23460908"],"is_preprint":false},{"year":2020,"finding":"O-GlcNAcylation of RBPR2 (the liver RBP4 receptor) by OGT disrupts retinol cascade in diabetic liver, reducing RBP4 uptake and contributing to RBP4 overproduction; OGT silencing reverses cellular retinol dyshomeostasis and RBP4 overproduction in high-glucose-treated hepatocytes. CRBP1 gene transfection also reverses RBP4 overproduction.","method":"Immunoprecipitation for O-GlcNAc-modified RBPR2, dual fluorescence, OGT silencing, CRBP1 transfection, Western blot in db/db and ob/ob mice and high-glucose hepatocytes","journal":"Metabolism: clinical and experimental","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, genetic rescue, and in vivo validation in multiple diabetic mouse models, single lab","pmids":["33065162"],"is_preprint":false},{"year":2023,"finding":"Succinate triggers M2 polarization of macrophages via SUCNR1, which promotes release of RBP4 from macrophages; secreted RBP4 then regulates endothelial tip cell formation and pathological angiogenesis via VEGFR2 signaling.","method":"Choroidal neovascularization and oxygen-induced retinopathy mouse models, macrophage polarization assays, endothelial cell migration/invasion/tubulation assays, SUCNR1 and VEGFR2 pathway analysis","journal":"Journal of neuroinflammation","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo models plus in vitro functional assays establishing RBP4/VEGFR2 pathway in angiogenesis, single lab","pmids":["38129891"],"is_preprint":false},{"year":2014,"finding":"RBP4 promotes proliferation of vascular smooth muscle cells (VSMCs) in the setting of hyperinsulinemia via activation of the MAPK/ERK1/2 signaling pathway; ERK1/2 inhibitor PD98059 blocks RBP4-induced VSMC proliferation, while JAK2 inhibition does not.","method":"Rat aortic smooth muscle cell (RASMC) culture, RBP4 treatment, ERK1/2 inhibitor PD98059, JAK2 inhibitor AG490, Western blot for p-ERK1/2 and p-JAK2, proliferation assay","journal":"Endocrine","confidence":"Medium","confidence_rationale":"Tier 2 — selective pathway inhibition with proliferation assay, single lab","pmids":["24888764"],"is_preprint":false},{"year":2022,"finding":"RBP4 promotes proliferation and migration of vascular smooth muscle cells via the JAK2/STAT3 signaling pathway; RBP4 overexpression increases JAK2, STAT3, cyclinD1, and Bcl-2 levels, while vitamin D supplementation lowers these markers and inhibits RBP4/JAK2/STAT3-induced VSMC proliferation.","method":"RBP4 overexpression plasmid transfection in VSMCs, vitamin D treatment, Western blot for JAK2/STAT3/cyclinD1/Bcl-2, rat diabetic atherosclerosis model","journal":"Oxidative medicine and cellular longevity","confidence":"Medium","confidence_rationale":"Tier 2 — overexpression plus pharmacological rescue with pathway markers, corroborated in vivo, single lab","pmids":["35082965"],"is_preprint":false},{"year":2018,"finding":"RBP4 overexpression in trophoblast cells (HTR8/SVneo) enhances proliferation and invasion via activation of PI3K/AKT signaling; RBP4 knockdown reduces proliferation, invasion, and MMP expression and suppresses PI3K/AKT phosphorylation.","method":"RBP4 overexpression and siRNA knockdown in HTR8/SVneo cells, CCK-8 proliferation assay, transwell invasion assay, Western blot for p-PI3K and p-AKT","journal":"Molecular medicine reports","confidence":"Medium","confidence_rationale":"Tier 2 — bidirectional manipulation (OE and KD) with pathway readouts, single lab","pmids":["30015949"],"is_preprint":false}],"current_model":"RBP4 is a lipocalin family protein synthesized primarily in hepatocytes that transports retinol in the circulation as part of a ternary complex with transthyretin (TTR), delivering retinol to tissues via the cell-surface receptor STRA6 and the liver/intestine receptor RBPR2; beyond retinol transport, RBP4 acts as an adipokine/hepatokine that activates innate immune cells (macrophages and APCs) through MyD88-dependent JNK/ERK/p38/NF-κB signaling to drive adaptive immune responses, promotes lipolysis in adipocytes, stimulates vascular smooth muscle cell proliferation via ERK and JAK2/STAT3 pathways, and activates STRA6 as a cytokine receptor to transduce JAK2-STAT3 signaling in muscle, colon, and other tissues, while TTR association prevents renal clearance of RBP4 and its circulating levels are regulated transcriptionally by HMGA1 downstream of cAMP/glucagon and post-translationally by O-GlcNAcylation of RBPR2 in diabetic states."},"narrative":{"teleology":[{"year":2009,"claim":"Establishing transcriptional regulation of RBP4: it was unknown how glucagon/cAMP controlled RBP4 expression; Hmga1-knockout mice revealed that HMGA1 is required for basal and cAMP-induced RBP4 transcription, linking hormonal signaling to RBP4 levels.","evidence":"Hmga1-knockout mice with glucagon challenge, qPCR, Western blot, GLUT4/Akt readouts in muscle and fat","pmids":["19460132"],"confidence":"Medium","gaps":["Single-lab finding without chromatin-level confirmation of HMGA1 occupancy at the Rbp4 promoter","Other transcriptional regulators of RBP4 not addressed"]},{"year":2012,"claim":"Identifying how liver and intestine take up RBP4-bound retinol: RBPR2 was discovered as a second RBP4 receptor structurally related to STRA6 that mediates retinol uptake in hepatic and intestinal cells, resolving the puzzle of retinol delivery to STRA6-negative tissues.","evidence":"Cell transfection with RBPR2, receptor binding assays, knockdown, retinol transport reconstitution","pmids":["23105095"],"confidence":"High","gaps":["RBPR2 crystal structure not determined","In vivo RBPR2 knockout not yet performed at this time"]},{"year":2013,"claim":"Developing pharmacological tools to lower circulating RBP4: the non-retinoid antagonist A1120 was shown to bind RBP4 with high affinity and disrupt the RBP4–TTR interaction, reducing serum RBP4 by ~75% without RAR agonism, establishing proof-of-concept for therapeutic RBP4 targeting.","evidence":"In vitro binding and TTR interaction assays, in vivo dosing in Abca4−/− mice with biochemical and electrophysiological endpoints","pmids":["23211825"],"confidence":"High","gaps":["Metabolic efficacy of A1120 not assessed in this study","Long-term safety and off-target effects not characterized"]},{"year":2014,"claim":"Revealing RBP4 as an immunomodulatory adipokine: it was unclear how elevated RBP4 caused insulin resistance; adoptive transfer experiments demonstrated that RBP4 directly activates antigen-presenting cells via JNK to drive Th1 CD4+ T cell responses, adipose tissue inflammation, and systemic insulin resistance.","evidence":"RBP4-overexpressing transgenic mice, adoptive transfer of APCs into wild-type recipients, JNK inhibition, glucose/insulin tolerance tests","pmids":["24606904"],"confidence":"High","gaps":["Identity of the RBP4 receptor on APCs not established","Whether retinol loading of RBP4 is required for APC activation not tested"]},{"year":2014,"claim":"Demonstrating TTR as a critical stabilizer of circulating RBP4 with metabolic consequences: TTR antisense knockdown reduced circulating RBP4 by 80–95% and improved whole-body insulin sensitivity by hyperinsulinemic clamp, establishing that TTR-dependent RBP4 stabilization is necessary for metabolic dysfunction.","evidence":"TTR antisense oligonucleotides in ob/ob and HFD mice, hyperinsulinemic-euglycemic clamp, tissue glucose uptake measurements","pmids":["25524914"],"confidence":"High","gaps":["Whether TTR knockdown benefits are entirely RBP4-dependent or partly due to loss of TTR itself","Renal handling kinetics of free RBP4 not quantified"]},{"year":2015,"claim":"Linking human RBP4 mutations to congenital eye disease: dominant-negative RBP4 missense mutations were found to abolish retinol binding yet increase STRA6 affinity, competitively blocking retinol delivery and causing ocular malformations through a maternal-effect mechanism.","evidence":"Family-based mutation identification, retinol and STRA6 binding assays on recombinant mutant proteins","pmids":["25910211"],"confidence":"High","gaps":["Structural basis of increased STRA6 affinity by mutant RBP4 not resolved","Whether other tissues are affected in mutation carriers not fully assessed"]},{"year":2016,"claim":"Resolving the hepatocyte as the dominant source of circulating RBP4: liver-specific RBP4 knockout eliminated detectable circulating RBP4 despite intact adipose expression, definitively establishing hepatocytes—not adipocytes—as the principal systemic source.","evidence":"Hepatocyte-specific Cre-lox Rbp4 knockout mice, serum RBP4 measurement, adipose tissue expression analysis","pmids":["27797907"],"confidence":"High","gaps":["Paracrine role of adipocyte-derived RBP4 within adipose tissue not excluded","Whether adipose RBP4 contributes to local inflammation independently of circulating pool not tested"]},{"year":2016,"claim":"Delineating the innate immune signaling pathway of RBP4: MyD88 knockout macrophages failed to respond to RBP4, establishing that RBP4 activates macrophages through MyD88-dependent MAPK/NF-κB signaling, and CTLA4-Ig blockade of costimulation in vivo reversed RBP4-driven insulin resistance.","evidence":"MyD88-KO macrophages, pathway inhibitors, CTLA4-Ig in RBP4-overexpressing mice, cytokine and metabolic readouts","pmids":["26936962"],"confidence":"High","gaps":["The specific pattern-recognition receptor upstream of MyD88 that senses RBP4 is not identified","Whether TLR4 or another TLR mediates the signal is unresolved"]},{"year":2016,"claim":"Demonstrating the essentiality of RBP4 for retinol mobilization and ocular integrity: Rbp4-knockout mice had undetectable serum retinol despite hepatic retinol accumulation and developed severe photoreceptor degeneration and choroidal atrophy.","evidence":"Rbp4-KO mice (C57BL/6), electroretinography, histology, serum/liver retinol quantification","pmids":["26974396"],"confidence":"High","gaps":["Whether dietary retinol supplementation can rescue ocular phenotype not tested","Contribution of retinoic acid versus retinol signaling to the degeneration not dissected"]},{"year":2017,"claim":"Establishing STRA6 as a cytokine receptor for RBP4 in cancer and muscle: RBP4–STRA6 interaction activates JAK2/STAT3 to maintain colon cancer stem cells and promote denervation-induced muscle atrophy; pharmacological RBP4 antagonist A1120 blocked muscle atrophy in vivo.","evidence":"STRA6/RBP4 knockdown in colon cancer cells and C2C12 myotubes, xenografts, denervation model, siRNA and inhibitor epistasis, A1120 rescue","pmids":["28689994","39031684"],"confidence":"High","gaps":["Whether JAK2/STAT3 activation is direct (STRA6 kinase-independent scaffolding) or requires additional co-receptors","Structural basis of STRA6 cytokine signaling versus transport function not resolved"]},{"year":2018,"claim":"Expanding the ligand repertoire of RBP4: high-resolution crystal structures revealed that plasma RBP4 binds fatty acids (palmitate, laurate) in its retinol-binding pocket, indicating RBP4 is not exclusively a retinol carrier.","evidence":"X-ray crystallography at 1.5 Å from plasma, urine, and amniotic fluid RBP4; mass spectrometry confirmation","pmids":["29414511"],"confidence":"High","gaps":["Functional consequence of fatty acid binding on STRA6 or RBPR2 signaling not tested","Relative occupancy of retinol versus fatty acid in vivo not determined"]},{"year":2020,"claim":"Demonstrating that RBP4 regulates adipocyte lipolysis both directly and through macrophage-derived TNFα, linking RBP4-driven immune activation to lipid metabolic dysfunction.","evidence":"RBP4 treatment of human adipocytes, conditioned media from RBP4-activated macrophages, lipolysis and cytokine assays","pmids":["32167208"],"confidence":"Medium","gaps":["Receptor mediating direct lipolytic effect on adipocytes not identified","In vivo lipolysis contribution of RBP4 not quantified"]},{"year":2020,"claim":"Revealing a diabetic-specific post-translational mechanism: O-GlcNAcylation of RBPR2 by OGT under high-glucose conditions impairs hepatic RBP4 uptake, contributing to RBP4 overproduction; OGT silencing restored retinol homeostasis.","evidence":"Immunoprecipitation for O-GlcNAc-RBPR2, OGT silencing, CRBP1 transfection rescue in db/db and ob/ob mice and high-glucose hepatocytes","pmids":["33065162"],"confidence":"Medium","gaps":["Specific O-GlcNAcylation site(s) on RBPR2 not mapped","Whether this mechanism operates in human diabetic liver not confirmed"]},{"year":2022,"claim":"Identifying an exosomal RBP4 feedback loop in NAFLD: hepatocyte-derived exosomal RBP4 polarizes Kupffer cells to M1 via NOX2/ROS/NF-κB, which secrete TNFα that activates STAT3 in hepatocytes to further upregulate RBP4, establishing a self-amplifying inflammatory circuit.","evidence":"Serum exosome characterization, Kupffer cell polarization assays, NOX2/NF-κB inhibition, TNFα treatment, in vivo RBP4 injection in HFD mice","pmids":["36572267"],"confidence":"Medium","gaps":["Whether exosomal versus free RBP4 has distinct receptor engagement not compared","Feedback loop not validated by genetic interruption in vivo"]},{"year":null,"claim":"The identity of the cell-surface receptor mediating RBP4's activation of antigen-presenting cells and macrophages (upstream of MyD88) remains unknown, and the structural basis for STRA6's dual function as retinol transporter and cytokine receptor has not been determined.","evidence":"","pmids":[],"confidence":"High","gaps":["No receptor for RBP4 on macrophages/APCs identified","No structural model of STRA6 in signaling versus transport mode","Relative physiological importance of retinol-dependent versus retinol-independent RBP4 signaling not quantified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,5,6,14]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1]},{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[2,3,7,8,9,10]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[4,6,14]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,3,7,8,9,19,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[2,3,10,13]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[0,5,14]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[5,7,13]}],"complexes":["RBP4–TTR complex"],"partners":["TTR","STRA6","RBPR2","JAK2","STAT3","MYD88"],"other_free_text":[]},"mechanistic_narrative":"RBP4 is a lipocalin-family retinol transport protein that functions both as the principal carrier of retinol in the circulation and as a signaling molecule that activates innate immune and metabolic pathways in diverse tissues. Synthesized predominantly by hepatocytes, RBP4 is stabilized in the circulation by transthyretin (TTR), which prevents its glomerular filtration; TTR knockdown reduces circulating RBP4 by 80–95% and improves insulin sensitivity [PMID:25524914], while Rbp4-knockout mice accumulate retinol in the liver but lack serum retinol and develop photoreceptor degeneration, demonstrating that RBP4 is essential for hepatic retinol mobilization [PMID:26974396]. RBP4 delivers retinol to peripheral tissues via the receptor STRA6 and to the liver/intestine via RBPR2 [PMID:23105095], and dominant-negative RBP4 mutations that increase STRA6 affinity while abolishing retinol binding cause congenital ocular malformations in humans [PMID:25910211]. Beyond retinol transport, RBP4 acts as an adipokine/hepatokine that activates antigen-presenting cells through MyD88-dependent JNK/ERK/p38/NF-κB signaling to drive adipose tissue inflammation and insulin resistance [PMID:24606904, PMID:26936962], engages STRA6 to transduce JAK2/STAT3 signaling in muscle and colon [PMID:39031684, PMID:28689994], and stimulates vascular smooth muscle cell proliferation through ERK1/2 and JAK2/STAT3 pathways [PMID:24888764, PMID:35082965]."},"prefetch_data":{"uniprot":{"accession":"P02753","full_name":"Retinol-binding protein 4","aliases":["Plasma retinol-binding protein","PRBP","RBP"],"length_aa":201,"mass_kda":23.0,"function":"Retinol-binding protein that mediates retinol transport in blood plasma (PubMed:5541771). Delivers retinol from the liver stores to the peripheral tissues (Probable). Transfers the bound all-trans retinol to STRA6, that then facilitates retinol transport across the cell membrane (PubMed:22665496)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P02753/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/RBP4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/RBP4","total_profiled":1310},"omim":[{"mim_id":"616428","title":"MICROPHTHALMIA/COLOBOMA 10; MCOPCB10","url":"https://www.omim.org/entry/616428"},{"mim_id":"615147","title":"RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME; RDCCAS","url":"https://www.omim.org/entry/615147"},{"mim_id":"610745","title":"STIMULATED BY RETINOIC ACID 6; STRA6","url":"https://www.omim.org/entry/610745"},{"mim_id":"600281","title":"HEPATOCYTE NUCLEAR FACTOR 4-ALPHA; HNF4A","url":"https://www.omim.org/entry/600281"},{"mim_id":"600165","title":"NANOPHTHALMOS 1; NNO1","url":"https://www.omim.org/entry/600165"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":11054.0}],"url":"https://www.proteinatlas.org/search/RBP4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P02753","domains":[{"cath_id":"2.40.128.20","chopping":"21-186","consensus_level":"medium","plddt":96.1744,"start":21,"end":186}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P02753","model_url":"https://alphafold.ebi.ac.uk/files/AF-P02753-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P02753-F1-predicted_aligned_error_v6.png","plddt_mean":90.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=RBP4","jax_strain_url":"https://www.jax.org/strain/search?query=RBP4"},"sequence":{"accession":"P02753","fasta_url":"https://rest.uniprot.org/uniprotkb/P02753.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P02753/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P02753"}},"corpus_meta":[{"pmid":"24606904","id":"PMC_24606904","title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.","date":"2014","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/24606904","citation_count":236,"is_preprint":false},{"pmid":"21835764","id":"PMC_21835764","title":"RBP4: a controversial adipokine.","date":"2011","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21835764","citation_count":180,"is_preprint":false},{"pmid":"17294166","id":"PMC_17294166","title":"Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.","date":"2007","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/17294166","citation_count":158,"is_preprint":false},{"pmid":"33790810","id":"PMC_33790810","title":"Biological Functions of RBP4 and Its Relevance for Human Diseases.","date":"2021","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/33790810","citation_count":148,"is_preprint":false},{"pmid":"16207746","id":"PMC_16207746","title":"Characterization of transgenic Arabidopsis plants overexpressing GR-RBP4 under high salinity, dehydration, or cold stress.","date":"2005","source":"Journal of experimental botany","url":"https://pubmed.ncbi.nlm.nih.gov/16207746","citation_count":117,"is_preprint":false},{"pmid":"23105095","id":"PMC_23105095","title":"Liver retinol transporter and receptor for serum retinol-binding protein (RBP4).","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23105095","citation_count":114,"is_preprint":false},{"pmid":"23584360","id":"PMC_23584360","title":"Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study.","date":"2013","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/23584360","citation_count":105,"is_preprint":false},{"pmid":"28689994","id":"PMC_28689994","title":"RBP4-STRA6 Pathway Drives Cancer Stem Cell Maintenance and Mediates High-Fat Diet-Induced Colon Carcinogenesis.","date":"2017","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28689994","citation_count":89,"is_preprint":false},{"pmid":"19816812","id":"PMC_19816812","title":"Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects.","date":"2009","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/19816812","citation_count":79,"is_preprint":false},{"pmid":"23211825","id":"PMC_23211825","title":"A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23211825","citation_count":78,"is_preprint":false},{"pmid":"27797907","id":"PMC_27797907","title":"Hepatocytes Are the Principal Source of Circulating RBP4 in Mice.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27797907","citation_count":71,"is_preprint":false},{"pmid":"18710473","id":"PMC_18710473","title":"Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18710473","citation_count":68,"is_preprint":false},{"pmid":"18752671","id":"PMC_18752671","title":"Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liver.","date":"2008","source":"Lipids in health and disease","url":"https://pubmed.ncbi.nlm.nih.gov/18752671","citation_count":63,"is_preprint":false},{"pmid":"26936962","id":"PMC_26936962","title":"Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26936962","citation_count":59,"is_preprint":false},{"pmid":"25910211","id":"PMC_25910211","title":"Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910211","citation_count":57,"is_preprint":false},{"pmid":"29642915","id":"PMC_29642915","title":"Adipokine RBP4 drives ovarian cancer cell migration.","date":"2018","source":"Journal of ovarian research","url":"https://pubmed.ncbi.nlm.nih.gov/29642915","citation_count":52,"is_preprint":false},{"pmid":"24956535","id":"PMC_24956535","title":"The relationship of novel adipokines, RBP4 and omentin-1, with carotid atherosclerosis severity and vulnerability.","date":"2014","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/24956535","citation_count":52,"is_preprint":false},{"pmid":"32167208","id":"PMC_32167208","title":"RBP4 increases lipolysis in human adipocytes and is associated with increased lipolysis and hepatic insulin resistance in obese women.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/32167208","citation_count":50,"is_preprint":false},{"pmid":"19288010","id":"PMC_19288010","title":"Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma.","date":"2009","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/19288010","citation_count":49,"is_preprint":false},{"pmid":"17526940","id":"PMC_17526940","title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome.","date":"2006","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/17526940","citation_count":49,"is_preprint":false},{"pmid":"26917947","id":"PMC_26917947","title":"Assessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Diabetic Patients with Nephropathy.","date":"2016","source":"Biomarker insights","url":"https://pubmed.ncbi.nlm.nih.gov/26917947","citation_count":48,"is_preprint":false},{"pmid":"20950077","id":"PMC_20950077","title":"Retinol binding protein 4 (RBP4) is primarily associated with adipose tissue mass in children.","date":"2010","source":"International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity","url":"https://pubmed.ncbi.nlm.nih.gov/20950077","citation_count":48,"is_preprint":false},{"pmid":"29759068","id":"PMC_29759068","title":"Childhood retinol-binding protein 4 (RBP4) levels predicting the 10-year risk of insulin resistance and metabolic syndrome: the BCAMS study.","date":"2018","source":"Cardiovascular diabetology","url":"https://pubmed.ncbi.nlm.nih.gov/29759068","citation_count":47,"is_preprint":false},{"pmid":"19460132","id":"PMC_19460132","title":"The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis.","date":"2009","source":"BMC biology","url":"https://pubmed.ncbi.nlm.nih.gov/19460132","citation_count":46,"is_preprint":false},{"pmid":"29414511","id":"PMC_29414511","title":"Human plasma retinol-binding protein (RBP4) is also a fatty acid-binding protein.","date":"2018","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/29414511","citation_count":45,"is_preprint":false},{"pmid":"25524914","id":"PMC_25524914","title":"Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25524914","citation_count":45,"is_preprint":false},{"pmid":"30126844","id":"PMC_30126844","title":"Liver-secreted RBP4 does not impair glucose homeostasis in mice.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30126844","citation_count":44,"is_preprint":false},{"pmid":"36572267","id":"PMC_36572267","title":"Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells.","date":"2022","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36572267","citation_count":44,"is_preprint":false},{"pmid":"2928844","id":"PMC_2928844","title":"Regional mapping of RBP4 to 10q23----q24 and RBP1 to 3q21----q22 in man.","date":"1989","source":"Somatic cell and molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/2928844","citation_count":43,"is_preprint":false},{"pmid":"20625434","id":"PMC_20625434","title":"Case-control analysis of SNPs in GLUT4, RBP4 and STRA6: association of SNPs in STRA6 with type 2 diabetes in a South Indian population.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20625434","citation_count":41,"is_preprint":false},{"pmid":"26286643","id":"PMC_26286643","title":"Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).","date":"2015","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/26286643","citation_count":38,"is_preprint":false},{"pmid":"18584408","id":"PMC_18584408","title":"Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1).","date":"2008","source":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18584408","citation_count":38,"is_preprint":false},{"pmid":"20544399","id":"PMC_20544399","title":"Association of retinol-binding protein-4 (RBP4) with lipid parameters in obese women.","date":"2010","source":"Obesity surgery","url":"https://pubmed.ncbi.nlm.nih.gov/20544399","citation_count":37,"is_preprint":false},{"pmid":"32095874","id":"PMC_32095874","title":"Novel adipokine associated with OA: retinol binding protein 4 (RBP4) is produced by cartilage and is correlated with MMPs in osteoarthritis patients.","date":"2020","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/32095874","citation_count":36,"is_preprint":false},{"pmid":"23129325","id":"PMC_23129325","title":"Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.","date":"2012","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/23129325","citation_count":34,"is_preprint":false},{"pmid":"34177800","id":"PMC_34177800","title":"RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia.","date":"2021","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34177800","citation_count":30,"is_preprint":false},{"pmid":"26974396","id":"PMC_26974396","title":"Severe ocular phenotypes in Rbp4-deficient mice in the C57BL/6 genetic background.","date":"2016","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/26974396","citation_count":29,"is_preprint":false},{"pmid":"18199128","id":"PMC_18199128","title":"Effect of RBP4 gene variants on circulating RBP4 concentration and type 2 diabetes in a Chinese population.","date":"2008","source":"Diabetic medicine : a journal of the British Diabetic Association","url":"https://pubmed.ncbi.nlm.nih.gov/18199128","citation_count":29,"is_preprint":false},{"pmid":"26611784","id":"PMC_26611784","title":"Association of RBP4 genetic variants with childhood obesity and cardiovascular risk factors.","date":"2015","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/26611784","citation_count":28,"is_preprint":false},{"pmid":"21324757","id":"PMC_21324757","title":"High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis.","date":"2011","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/21324757","citation_count":28,"is_preprint":false},{"pmid":"18466349","id":"PMC_18466349","title":"Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.","date":"2008","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/18466349","citation_count":28,"is_preprint":false},{"pmid":"21039728","id":"PMC_21039728","title":"Human RBP4 adipose tissue expression is gender specific and influenced by leptin.","date":"2011","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21039728","citation_count":27,"is_preprint":false},{"pmid":"22253430","id":"PMC_22253430","title":"Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay.","date":"2012","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/22253430","citation_count":27,"is_preprint":false},{"pmid":"28026829","id":"PMC_28026829","title":"Retinol-binding protein 4 (RBP4) as the causative factor and marker of vascular injury related to insulin resistance.","date":"2016","source":"Postepy higieny i medycyny doswiadczalnej (Online)","url":"https://pubmed.ncbi.nlm.nih.gov/28026829","citation_count":26,"is_preprint":false},{"pmid":"24994759","id":"PMC_24994759","title":"Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria.","date":"2014","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24994759","citation_count":26,"is_preprint":false},{"pmid":"20798476","id":"PMC_20798476","title":"Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese--the Tanno and Sobetsu study.","date":"2010","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/20798476","citation_count":25,"is_preprint":false},{"pmid":"24695672","id":"PMC_24695672","title":"Proteomic Analysis of RBP4/Vitamin A in Children with Cleft Lip and/or Palate.","date":"2014","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/24695672","citation_count":24,"is_preprint":false},{"pmid":"29524177","id":"PMC_29524177","title":"Components of metabolic syndrome in relation to plasma levels of retinol binding protein 4 (RBP4) in a cohort of people aged 65 years and older.","date":"2018","source":"Journal of endocrinological investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29524177","citation_count":24,"is_preprint":false},{"pmid":"22670657","id":"PMC_22670657","title":"Serum FGF21 and RBP4 levels in patients with chronic hepatitis C.","date":"2012","source":"Scandinavian journal of gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/22670657","citation_count":24,"is_preprint":false},{"pmid":"30015949","id":"PMC_30015949","title":"RBP4 regulates trophoblastic cell proliferation and invasion via the PI3K/AKT signaling pathway.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30015949","citation_count":24,"is_preprint":false},{"pmid":"28528355","id":"PMC_28528355","title":"Increased retinol-free RBP4 contributes to insulin resistance in gestational diabetes mellitus.","date":"2017","source":"Archives of gynecology and obstetrics","url":"https://pubmed.ncbi.nlm.nih.gov/28528355","citation_count":23,"is_preprint":false},{"pmid":"34786060","id":"PMC_34786060","title":"LncRNA PTGS2 regulates islet β-cell function through the miR-146a-5p/RBP4 axis and its diagnostic value in type 2 diabetes mellitus.","date":"2021","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/34786060","citation_count":22,"is_preprint":false},{"pmid":"19893506","id":"PMC_19893506","title":"Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population.","date":"2009","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/19893506","citation_count":21,"is_preprint":false},{"pmid":"29122953","id":"PMC_29122953","title":"Dietary weight loss-induced changes in RBP4, FFA, and ACE predict weight regain in people with overweight and obesity.","date":"2017","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/29122953","citation_count":21,"is_preprint":false},{"pmid":"27892788","id":"PMC_27892788","title":"Vitamin A deficiency due to bi-allelic mutation of RBP4: There's more to it than meets the eye.","date":"2016","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27892788","citation_count":21,"is_preprint":false},{"pmid":"39031684","id":"PMC_39031684","title":"RBP4 promotes denervation-induced muscle atrophy through STRA6-dependent pathway.","date":"2024","source":"Journal of cachexia, sarcopenia and muscle","url":"https://pubmed.ncbi.nlm.nih.gov/39031684","citation_count":20,"is_preprint":false},{"pmid":"19053019","id":"PMC_19053019","title":"Human fetal adiponectin and retinol-binding protein (RBP)-4 levels in relation to birth weight and maternal obesity.","date":"2008","source":"Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association","url":"https://pubmed.ncbi.nlm.nih.gov/19053019","citation_count":20,"is_preprint":false},{"pmid":"35629362","id":"PMC_35629362","title":"Green Coffee Bean Extract Normalize Obesity-Induced Alterations of Metabolic Parameters in Rats by Upregulating Adiponectin and GLUT4 Levels and Reducing RBP-4 and HOMA-IR.","date":"2022","source":"Life (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35629362","citation_count":20,"is_preprint":false},{"pmid":"33082885","id":"PMC_33082885","title":"The Role of Circulating RBP4 in the Type 2 Diabetes Patients with Kidney Diseases: A Systematic Review and Meta-Analysis.","date":"2020","source":"Disease markers","url":"https://pubmed.ncbi.nlm.nih.gov/33082885","citation_count":20,"is_preprint":false},{"pmid":"20576168","id":"PMC_20576168","title":"Non-additive effects of RBP4, ESR1 and IGF2 polymorphisms on litter size at different parities in a Chinese-European porcine line.","date":"2010","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/20576168","citation_count":20,"is_preprint":false},{"pmid":"31054116","id":"PMC_31054116","title":"The influence of Visfatin, RBP-4 and insulin resistance on bone mineral density in women with treated primary osteoporosis.","date":"2019","source":"Aging clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/31054116","citation_count":20,"is_preprint":false},{"pmid":"18537906","id":"PMC_18537906","title":"Effect of polymorphisms in the genes for LIF and RBP4 on litter size in two German pig lines.","date":"2008","source":"Reproduction in domestic animals = Zuchthygiene","url":"https://pubmed.ncbi.nlm.nih.gov/18537906","citation_count":20,"is_preprint":false},{"pmid":"38129891","id":"PMC_38129891","title":"Succinate-induced macrophage polarization and RBP4 secretion promote vascular sprouting in ocular neovascularization.","date":"2023","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38129891","citation_count":19,"is_preprint":false},{"pmid":"30805369","id":"PMC_30805369","title":"Relationships of SLC2A4, RBP4, PCK1, and PI3K Gene Polymorphisms with Gestational Diabetes Mellitus in a Chinese Population.","date":"2019","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/30805369","citation_count":19,"is_preprint":false},{"pmid":"33376518","id":"PMC_33376518","title":"Determination of FABP4, RBP4 and the MMP-9/NGAL complex in the serum of women with breast cancer.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33376518","citation_count":19,"is_preprint":false},{"pmid":"22697121","id":"PMC_22697121","title":"Alterations in systemic concentrations of progesterone during the early luteal phase affect RBP4 expression in the bovine uterus.","date":"2012","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/22697121","citation_count":19,"is_preprint":false},{"pmid":"37312059","id":"PMC_37312059","title":"Shift work is associated with an increased risk of type 2 diabetes and elevated RBP4 level: cross sectional analysis from the OHSPIW cohort study.","date":"2023","source":"BMC public health","url":"https://pubmed.ncbi.nlm.nih.gov/37312059","citation_count":18,"is_preprint":false},{"pmid":"23028466","id":"PMC_23028466","title":"Valproic acid downregulates RBP4 and elicits hypervitaminosis A-teratogenesis--a kinetic analysis on retinol/retinoic acid homeostatic system.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23028466","citation_count":18,"is_preprint":false},{"pmid":"31956331","id":"PMC_31956331","title":"Retinol and vitamin A metabolites accumulate through RBP4 and STRA6 changes in a psoriasis murine model.","date":"2020","source":"Nutrition & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31956331","citation_count":17,"is_preprint":false},{"pmid":"24888764","id":"PMC_24888764","title":"Involvement of RBP4 in hyperinsulinism-induced vascular smooth muscle cell proliferation.","date":"2014","source":"Endocrine","url":"https://pubmed.ncbi.nlm.nih.gov/24888764","citation_count":17,"is_preprint":false},{"pmid":"23460908","id":"PMC_23460908","title":"Interleukin-1β downregulates RBP4 secretion in human adipocytes.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23460908","citation_count":17,"is_preprint":false},{"pmid":"24739026","id":"PMC_24739026","title":"Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.","date":"2014","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24739026","citation_count":17,"is_preprint":false},{"pmid":"23408763","id":"PMC_23408763","title":"Metabolic syndrome, circulating RBP4, testosterone, and SHBG predict weight regain at 6 months after weight loss in men.","date":"2013","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23408763","citation_count":17,"is_preprint":false},{"pmid":"35082965","id":"PMC_35082965","title":"The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway.","date":"2022","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/35082965","citation_count":17,"is_preprint":false},{"pmid":"35631143","id":"PMC_35631143","title":"Significantly Reduced Retinol Binding Protein 4 (RBP4) Levels in Critically Ill COVID-19 Patients.","date":"2022","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/35631143","citation_count":16,"is_preprint":false},{"pmid":"25479076","id":"PMC_25479076","title":"A genetic polymorphism in RBP4 is associated with coronary artery disease.","date":"2014","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25479076","citation_count":16,"is_preprint":false},{"pmid":"18324929","id":"PMC_18324929","title":"High circulating levels of RBP4 and mRNA levels of aP2, PGC-1alpha and UCP-2 predict improvement in insulin sensitivity following pioglitazone treatment of drug-naïve type 2 diabetic subjects.","date":"2008","source":"Journal of internal medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18324929","citation_count":16,"is_preprint":false},{"pmid":"29786448","id":"PMC_29786448","title":"Serum RBP4 positively correlates with triglyceride level but not with BMI, fat mass and insulin resistance in healthy obese and non-obese individuals.","date":"2018","source":"Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals","url":"https://pubmed.ncbi.nlm.nih.gov/29786448","citation_count":16,"is_preprint":false},{"pmid":"21521262","id":"PMC_21521262","title":"High plasma retinol binding protein 4 (RBP4) is associated with systemic inflammation independently of low RBP4 adipose expression and is normalized by transplantation in nonobese, nondiabetic patients with chronic kidney disease.","date":"2011","source":"Clinical endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21521262","citation_count":16,"is_preprint":false},{"pmid":"28499807","id":"PMC_28499807","title":"Evaluation of insulin-like growth factor (IGF-1) and retinol binding protein (RBP-4) levels in patients with newly diagnosed pancreatic adenocarcinoma (PDAC).","date":"2017","source":"Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/28499807","citation_count":14,"is_preprint":false},{"pmid":"30186876","id":"PMC_30186876","title":"Involvement of RBP4 in Diabetic Atherosclerosis and the Role of Vitamin D Intervention.","date":"2018","source":"Journal of diabetes research","url":"https://pubmed.ncbi.nlm.nih.gov/30186876","citation_count":14,"is_preprint":false},{"pmid":"21406189","id":"PMC_21406189","title":"Circulating Nampt and RBP4 levels in patients with carotid stenosis undergoing carotid endarterectomy (CEA).","date":"2011","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21406189","citation_count":14,"is_preprint":false},{"pmid":"34856473","id":"PMC_34856473","title":"A novel regulatory mechanism of geniposide for improving glucose homeostasis mediated by circulating RBP4.","date":"2021","source":"Phytomedicine : international journal of phytotherapy and phytopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34856473","citation_count":14,"is_preprint":false},{"pmid":"28813718","id":"PMC_28813718","title":"Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration.","date":"2017","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/28813718","citation_count":13,"is_preprint":false},{"pmid":"33484131","id":"PMC_33484131","title":"Systematic Quantification of Neurotrophic Adipokines RBP4, PEDF, and Clusterin in Human Cerebrospinal Fluid and Serum.","date":"2021","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/33484131","citation_count":13,"is_preprint":false},{"pmid":"29428584","id":"PMC_29428584","title":"The preliminary association study of ADIPOQ, RBP4, and BCMO1 variants with polycystic ovary syndrome and with biochemical characteristics in a cohort of Polish women.","date":"2018","source":"Advances in medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29428584","citation_count":13,"is_preprint":false},{"pmid":"29847795","id":"PMC_29847795","title":"Maternal Inheritance of a Recessive RBP4 Defect in Canine Congenital Eye Disease.","date":"2018","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/29847795","citation_count":13,"is_preprint":false},{"pmid":"31659433","id":"PMC_31659433","title":"Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31659433","citation_count":13,"is_preprint":false},{"pmid":"28038989","id":"PMC_28038989","title":"Increased plasma RBP4 concentration in older hypertensives is related to the decreased kidney function and the number of antihypertensive drugs-results from the PolSenior substudy.","date":"2016","source":"Journal of the American Society of Hypertension : JASH","url":"https://pubmed.ncbi.nlm.nih.gov/28038989","citation_count":13,"is_preprint":false},{"pmid":"33198782","id":"PMC_33198782","title":"Retinol-binding protein 4 (RBP4) and high sensitivity C-reactive protein (hs-CRP) levels in patients with diminished ovarian reserve (DOR): a cross-sectional study.","date":"2020","source":"Reproductive biology and endocrinology : RB&E","url":"https://pubmed.ncbi.nlm.nih.gov/33198782","citation_count":13,"is_preprint":false},{"pmid":"23979787","id":"PMC_23979787","title":"The effects of weight loss on FABP4 and RBP4 in obese women with metabolic syndrome.","date":"2013","source":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme","url":"https://pubmed.ncbi.nlm.nih.gov/23979787","citation_count":12,"is_preprint":false},{"pmid":"23496280","id":"PMC_23496280","title":"Gender dimorphic increase in RBP-4 and NGAL in children born after IVF: an epigenetic phenomenon?","date":"2013","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/23496280","citation_count":12,"is_preprint":false},{"pmid":"30697570","id":"PMC_30697570","title":"Correlation Between Tenofovir Drug Levels and the Renal Biomarkers RBP-4 and ß2M in the ION-4 Study Cohort.","date":"2019","source":"Open forum infectious diseases","url":"https://pubmed.ncbi.nlm.nih.gov/30697570","citation_count":12,"is_preprint":false},{"pmid":"26885398","id":"PMC_26885398","title":"Association of RBP4 Genotype with Phenotypic Reproductive Traits of Sows.","date":"2016","source":"Genetics research international","url":"https://pubmed.ncbi.nlm.nih.gov/26885398","citation_count":12,"is_preprint":false},{"pmid":"27824510","id":"PMC_27824510","title":"Association of BF, RBP4, and ESR2 Genotypes with Litter Size in an Autochthonous Pig Population.","date":"2016","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/27824510","citation_count":12,"is_preprint":false},{"pmid":"35883591","id":"PMC_35883591","title":"Effect of Upregulation of Transcription Factor TFDP1 Binding Promoter Activity Due to RBP4 g.36491960G>C Mutation on the Proliferation of Goat Granulosa Cells.","date":"2022","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/35883591","citation_count":12,"is_preprint":false},{"pmid":"38532976","id":"PMC_38532976","title":"Retinol-binding protein 4 (RBP4) circulating levels and gestational diabetes mellitus: a systematic review and meta-analysis.","date":"2024","source":"Frontiers in public health","url":"https://pubmed.ncbi.nlm.nih.gov/38532976","citation_count":12,"is_preprint":false},{"pmid":"24397358","id":"PMC_24397358","title":"Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women.","date":"2014","source":"Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/24397358","citation_count":12,"is_preprint":false},{"pmid":"33065162","id":"PMC_33065162","title":"Disruption of retinoid homeostasis induces RBP4 overproduction in diabetes: O-GlcNAcylation involved.","date":"2020","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/33065162","citation_count":11,"is_preprint":false},{"pmid":"29900277","id":"PMC_29900277","title":"High resolution crystal structure data of human plasma retinol-binding protein (RBP4) bound to retinol and fatty acids.","date":"2018","source":"Data in brief","url":"https://pubmed.ncbi.nlm.nih.gov/29900277","citation_count":11,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":57923,"output_tokens":5510,"usd":0.12821},"stage2":{"model":"claude-opus-4-6","input_tokens":9090,"output_tokens":3926,"usd":0.2154},"total_usd":0.34361,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"RBPR2, a novel retinol transporter structurally related to STRA6, was identified as the liver and intestinal receptor for RBP4. Expression of RBPR2 in cultured cells confers high-affinity RBP4 binding and retinol transport, and RBPR2 knockdown reduces RBP4 binding and retinol transport.\",\n      \"method\": \"Cell transfection, receptor binding assay, knockdown, in vitro retinol transport assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional reconstitution in cells plus knockdown with direct transport readout, single paper with multiple orthogonal methods\",\n      \"pmids\": [\"23105095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Human plasma RBP4 binds fatty acids (palmitic and lauric acid) in its hydrophobic ligand-binding pocket in addition to retinol, as determined by high-resolution crystal structures confirmed by mass spectrometry.\",\n      \"method\": \"X-ray crystallography (1.5 Å resolution), mass spectrometry\",\n      \"journal\": \"Biochimica et biophysica acta. Molecular and cell biology of lipids\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with orthogonal MS confirmation, multiple crystal forms (plasma, urine, amniotic fluid)\",\n      \"pmids\": [\"29414511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RBP4 causes adipose tissue inflammation and systemic insulin resistance by directly activating antigen-presenting cells (APCs) through a JNK-dependent pathway, which then elicits CD4 T cell Th1 polarization. Transfer of RBP4-activated APCs into normal mice is sufficient to induce AT inflammation and insulin resistance.\",\n      \"method\": \"RBP4-overexpressing transgenic mice, adoptive transfer of APCs, JNK pathway inhibition, glucose/insulin tolerance tests\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via adoptive transfer, pathway inhibition, multiple in vivo readouts; replicated mechanistically in follow-up study (PMID:26936962)\",\n      \"pmids\": [\"24606904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"RBP4-induced macrophage antigen presentation and T-cell activation requires MyD88 and downstream MAPK (JNK, ERK, p38) and NF-κB pathways; in MyD88-deficient macrophages RBP4 fails to stimulate TNF, IL-12, and IL-6 secretion. In vivo blockade of antigen presentation with CTLA4-Ig reduces AT inflammation and improves insulin resistance in RBP4-overexpressing mice.\",\n      \"method\": \"MyD88 knockout macrophages, pathway inhibitors, CTLA4-Ig in vivo blockade, cytokine measurement, insulin/glucose tolerance tests\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO plus pharmacological rescue plus in vivo intervention; multiple orthogonal methods\",\n      \"pmids\": [\"26936962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hepatocytes are the principal source of circulating RBP4; liver-specific RBP4 knockout mice have undetectable circulating RBP4 despite intact adipose tissue RBP4 expression and secretion, even in diet-induced insulin resistance.\",\n      \"method\": \"Hepatocyte-specific Cre-lox RBP4 knockout mice, circulating RBP4 measurement, adipose tissue RBP4 expression analysis\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with definitive source-of-circulating-protein readout; directly falsifies adipocyte origin hypothesis\",\n      \"pmids\": [\"27797907\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dominant-negative missense mutations in RBP4 greatly reduce retinol binding but paradoxically increase affinity for the cell-surface receptor STRA6, thereby competitively blocking retinol delivery from wild-type RBP4 to fetal and placental tissues and causing ocular malformations.\",\n      \"method\": \"Missense mutation identification in families, retinol binding assays, STRA6 binding assays, functional characterization of mutant proteins\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical assays of retinol and receptor binding combined with human genetics and maternal transmission analysis; multiple orthogonal approaches\",\n      \"pmids\": [\"25910211\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Circulating transthyretin (TTR) stabilizes RBP4 by preventing its glomerular filtration; antisense oligonucleotide knockdown of TTR reduces circulating RBP4 by 80-95% and improves insulin sensitivity, hepatic glucose production suppression, and muscle glucose uptake in obese mice.\",\n      \"method\": \"TTR antisense oligonucleotides in ob/ob and HFD mice, hyperinsulinemic-euglycemic clamp, glucose uptake measurement, insulin signaling assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic/pharmacological manipulation with quantitative metabolic readouts in multiple mouse models; clamp studies provide definitive insulin sensitivity measurement\",\n      \"pmids\": [\"25524914\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"RBP4 activates STRA6 as a cytokine receptor to transduce a JAK2-STAT3 signaling cascade, which promotes cancer stem cell maintenance and tumor initiation in colon cancer; downregulation of STRA6 or RBP4 decreases cancer stem cell fraction and sphere/tumor initiation frequency.\",\n      \"method\": \"STRA6/RBP4 knockdown in colon cancer cells, sphere formation assay, xenograft mouse model, flow cytometry for cancer stem cells\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — knockdown with multiple cellular and in vivo readouts, single lab\",\n      \"pmids\": [\"28689994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Retinol-bound (holo-)RBP4 activates STRA6 and downstream JAK2/STAT3 signaling to promote denervation-induced muscle atrophy and fat infiltration; inhibition of STRA6, JAK2, or STAT3 (by siRNA or inhibitors) reduces Atrogin-1 and MuRF1 upregulation and protects myotube diameter. Pharmacological RBP4 antagonist A1120 inhibits this pathway and ameliorates muscle atrophy in vivo.\",\n      \"method\": \"RBP4 knockout mice, intramuscular injection of holo- vs apo-RBP4, siRNA knockdown of STRA6/JAK2/STAT3, specific pathway inhibitors, C2C12 myotube assays, denervation model, A1120 pharmacological blockade\",\n      \"journal\": \"Journal of cachexia, sarcopenia and muscle\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO, reconstitution with recombinant proteins, siRNA pathway dissection, pharmacological rescue; multiple orthogonal methods in one study\",\n      \"pmids\": [\"39031684\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Apo-RBP4 (retinol-free form) functions as a ligand that activates STRA6 and downstream JAK2/STAT5 cascade, leading to SOCS3 upregulation, decreased phosphorylation of IR and IRS1, attenuated GLUT4 translocation, and insulin resistance. Co-immunoprecipitation confirmed prolonged apo-RBP4/STRA6 interaction compared to holo-RBP4.\",\n      \"method\": \"Co-immunoprecipitation, Western blotting, immunofluorescence, in vivo apo-RBP4 injection in pregnant rats, primary human adipocyte culture\",\n      \"journal\": \"Archives of gynecology and obstetrics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus in vivo and in vitro functional validation, single lab\",\n      \"pmids\": [\"28528355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"RBP4 directly stimulates basal lipolysis in human adipocytes in vitro; RBP4-activated macrophages produce TNFα that markedly increases basal lipolysis and impairs insulin-mediated lipolysis suppression in adipocytes.\",\n      \"method\": \"RBP4 treatment of human adipocytes, conditioned media from RBP4-activated macrophages, lipolysis assays, cytokine measurement\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct in vitro functional assay in human cells with mechanistic dissection, single lab\",\n      \"pmids\": [\"32167208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"HMGA1 is a transcriptional regulator required for basal and cAMP-induced RBP4 gene and protein expression; glucagon (via cAMP) upregulates both HMGA1 and RBP4 in wild-type mice, while Hmga1-knockout mice show severely attenuated RBP4 expression correlated with increased GLUT4 and Akt activation in muscle and fat.\",\n      \"method\": \"Hmga1-knockout mouse model, glucagon administration, qPCR, Western blotting, GLUT4 and Akt assays in multiple tissues\",\n      \"journal\": \"BMC biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic KO with in vivo hormonal challenge and multiple downstream readouts, single lab\",\n      \"pmids\": [\"19460132\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Non-retinoid RBP4 antagonist A1120 binds RBP4 with high affinity and inhibits the RBP4-TTR interaction, reducing serum RBP4 by 75% in mice and correlating with reduction in visual cycle retinoids and ocular lipofuscin bisretinoids, without acting as a RARα agonist unlike fenretinide.\",\n      \"method\": \"In vitro RBP4 binding assay, RBP4-TTR interaction assay, RPE microsome isomerohydrolase assay, in vivo mouse dosing (Abca4−/− model), biochemical and electrophysiological analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding reconstitution plus in vivo mechanistic validation with multiple biochemical endpoints and receptor specificity characterization\",\n      \"pmids\": [\"23211825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Exosomal RBP4 from hepatocytes promotes M1-like polarization of Kupffer cells via NOX2/ROS/NF-κB pathway, which then induces TNFα secretion that activates STAT3 in hepatocytes to further upregulate RBP4 transcription, creating a positive feedback loop promoting NAFLD.\",\n      \"method\": \"Serum exosome characterization, Kupffer cell polarization assays, NOX2/NF-κB inhibition, TNFα treatment of hepatocytes, intravenous RBP4 injection in HFD mice, lipogenesis gene expression\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro pathway dissection plus in vivo reconstitution with recombinant protein, single lab\",\n      \"pmids\": [\"36572267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Rbp4-deficient mice in the C57BL/6 background accumulate retinol in the liver but have undetectable serum retinol, demonstrating that RBP4 is critical for mobilization of retinol from hepatic storage pools; these mice develop severe ocular phenotypes including photoreceptor degeneration, loss of choroid, and persistent hyaloid artery.\",\n      \"method\": \"Rbp4-knockout mouse model, electroretinography, histological analysis, retinol quantification in serum and liver\",\n      \"journal\": \"Laboratory investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with definitive biochemical (retinol mobilization) and structural/functional (ERG, histology) readouts\",\n      \"pmids\": [\"26974396\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"A canine RBP4 K12del mutation near the N-terminus disrupts RBP4 folding in vivo, decreasing its secretion from hepatocytes to serum, and causes ocular malformations only when both dam and offspring carry the deletion homozygously, demonstrating recessive maternal inheritance through impaired sequential retinol transfer across the placenta.\",\n      \"method\": \"Whole genome sequencing, in vivo secretion assays, NMR structural analysis (implied by Permi co-author), maternal-fetal transmission analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic identification with in vivo functional characterization of secretion defect and mechanistic explanation of maternal inheritance\",\n      \"pmids\": [\"29847795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IL-1β downregulates RBP4 mRNA expression and secretion in human adipocytes in a time- and dose-dependent manner, mediated through the IL-1 receptor and NF-κB pathway; IL-1 receptor blocking antibody and NF-κB inhibitors reverse this effect.\",\n      \"method\": \"Human SGBS and primary adipocytes treated with recombinant cytokines and macrophage conditioned media, qPCR, ELISA, IL-1R blocking antibody, NF-κB inhibitors (CAPE, SC-514)\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — receptor blocking and pathway inhibition with multiple human cell models, single lab\",\n      \"pmids\": [\"23460908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"O-GlcNAcylation of RBPR2 (the liver RBP4 receptor) by OGT disrupts retinol cascade in diabetic liver, reducing RBP4 uptake and contributing to RBP4 overproduction; OGT silencing reverses cellular retinol dyshomeostasis and RBP4 overproduction in high-glucose-treated hepatocytes. CRBP1 gene transfection also reverses RBP4 overproduction.\",\n      \"method\": \"Immunoprecipitation for O-GlcNAc-modified RBPR2, dual fluorescence, OGT silencing, CRBP1 transfection, Western blot in db/db and ob/ob mice and high-glucose hepatocytes\",\n      \"journal\": \"Metabolism: clinical and experimental\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, genetic rescue, and in vivo validation in multiple diabetic mouse models, single lab\",\n      \"pmids\": [\"33065162\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Succinate triggers M2 polarization of macrophages via SUCNR1, which promotes release of RBP4 from macrophages; secreted RBP4 then regulates endothelial tip cell formation and pathological angiogenesis via VEGFR2 signaling.\",\n      \"method\": \"Choroidal neovascularization and oxygen-induced retinopathy mouse models, macrophage polarization assays, endothelial cell migration/invasion/tubulation assays, SUCNR1 and VEGFR2 pathway analysis\",\n      \"journal\": \"Journal of neuroinflammation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo models plus in vitro functional assays establishing RBP4/VEGFR2 pathway in angiogenesis, single lab\",\n      \"pmids\": [\"38129891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"RBP4 promotes proliferation of vascular smooth muscle cells (VSMCs) in the setting of hyperinsulinemia via activation of the MAPK/ERK1/2 signaling pathway; ERK1/2 inhibitor PD98059 blocks RBP4-induced VSMC proliferation, while JAK2 inhibition does not.\",\n      \"method\": \"Rat aortic smooth muscle cell (RASMC) culture, RBP4 treatment, ERK1/2 inhibitor PD98059, JAK2 inhibitor AG490, Western blot for p-ERK1/2 and p-JAK2, proliferation assay\",\n      \"journal\": \"Endocrine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — selective pathway inhibition with proliferation assay, single lab\",\n      \"pmids\": [\"24888764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"RBP4 promotes proliferation and migration of vascular smooth muscle cells via the JAK2/STAT3 signaling pathway; RBP4 overexpression increases JAK2, STAT3, cyclinD1, and Bcl-2 levels, while vitamin D supplementation lowers these markers and inhibits RBP4/JAK2/STAT3-induced VSMC proliferation.\",\n      \"method\": \"RBP4 overexpression plasmid transfection in VSMCs, vitamin D treatment, Western blot for JAK2/STAT3/cyclinD1/Bcl-2, rat diabetic atherosclerosis model\",\n      \"journal\": \"Oxidative medicine and cellular longevity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — overexpression plus pharmacological rescue with pathway markers, corroborated in vivo, single lab\",\n      \"pmids\": [\"35082965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"RBP4 overexpression in trophoblast cells (HTR8/SVneo) enhances proliferation and invasion via activation of PI3K/AKT signaling; RBP4 knockdown reduces proliferation, invasion, and MMP expression and suppresses PI3K/AKT phosphorylation.\",\n      \"method\": \"RBP4 overexpression and siRNA knockdown in HTR8/SVneo cells, CCK-8 proliferation assay, transwell invasion assay, Western blot for p-PI3K and p-AKT\",\n      \"journal\": \"Molecular medicine reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — bidirectional manipulation (OE and KD) with pathway readouts, single lab\",\n      \"pmids\": [\"30015949\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"RBP4 is a lipocalin family protein synthesized primarily in hepatocytes that transports retinol in the circulation as part of a ternary complex with transthyretin (TTR), delivering retinol to tissues via the cell-surface receptor STRA6 and the liver/intestine receptor RBPR2; beyond retinol transport, RBP4 acts as an adipokine/hepatokine that activates innate immune cells (macrophages and APCs) through MyD88-dependent JNK/ERK/p38/NF-κB signaling to drive adaptive immune responses, promotes lipolysis in adipocytes, stimulates vascular smooth muscle cell proliferation via ERK and JAK2/STAT3 pathways, and activates STRA6 as a cytokine receptor to transduce JAK2-STAT3 signaling in muscle, colon, and other tissues, while TTR association prevents renal clearance of RBP4 and its circulating levels are regulated transcriptionally by HMGA1 downstream of cAMP/glucagon and post-translationally by O-GlcNAcylation of RBPR2 in diabetic states.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"RBP4 is a lipocalin-family retinol transport protein that functions both as the principal carrier of retinol in the circulation and as a signaling molecule that activates innate immune and metabolic pathways in diverse tissues. Synthesized predominantly by hepatocytes, RBP4 is stabilized in the circulation by transthyretin (TTR), which prevents its glomerular filtration; TTR knockdown reduces circulating RBP4 by 80–95% and improves insulin sensitivity [PMID:25524914], while Rbp4-knockout mice accumulate retinol in the liver but lack serum retinol and develop photoreceptor degeneration, demonstrating that RBP4 is essential for hepatic retinol mobilization [PMID:26974396]. RBP4 delivers retinol to peripheral tissues via the receptor STRA6 and to the liver/intestine via RBPR2 [PMID:23105095], and dominant-negative RBP4 mutations that increase STRA6 affinity while abolishing retinol binding cause congenital ocular malformations in humans [PMID:25910211]. Beyond retinol transport, RBP4 acts as an adipokine/hepatokine that activates antigen-presenting cells through MyD88-dependent JNK/ERK/p38/NF-κB signaling to drive adipose tissue inflammation and insulin resistance [PMID:24606904, PMID:26936962], engages STRA6 to transduce JAK2/STAT3 signaling in muscle and colon [PMID:39031684, PMID:28689994], and stimulates vascular smooth muscle cell proliferation through ERK1/2 and JAK2/STAT3 pathways [PMID:24888764, PMID:35082965].\",\n  \"teleology\": [\n    {\n      \"year\": 2009,\n      \"claim\": \"Establishing transcriptional regulation of RBP4: it was unknown how glucagon/cAMP controlled RBP4 expression; Hmga1-knockout mice revealed that HMGA1 is required for basal and cAMP-induced RBP4 transcription, linking hormonal signaling to RBP4 levels.\",\n      \"evidence\": \"Hmga1-knockout mice with glucagon challenge, qPCR, Western blot, GLUT4/Akt readouts in muscle and fat\",\n      \"pmids\": [\"19460132\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without chromatin-level confirmation of HMGA1 occupancy at the Rbp4 promoter\", \"Other transcriptional regulators of RBP4 not addressed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identifying how liver and intestine take up RBP4-bound retinol: RBPR2 was discovered as a second RBP4 receptor structurally related to STRA6 that mediates retinol uptake in hepatic and intestinal cells, resolving the puzzle of retinol delivery to STRA6-negative tissues.\",\n      \"evidence\": \"Cell transfection with RBPR2, receptor binding assays, knockdown, retinol transport reconstitution\",\n      \"pmids\": [\"23105095\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"RBPR2 crystal structure not determined\", \"In vivo RBPR2 knockout not yet performed at this time\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Developing pharmacological tools to lower circulating RBP4: the non-retinoid antagonist A1120 was shown to bind RBP4 with high affinity and disrupt the RBP4–TTR interaction, reducing serum RBP4 by ~75% without RAR agonism, establishing proof-of-concept for therapeutic RBP4 targeting.\",\n      \"evidence\": \"In vitro binding and TTR interaction assays, in vivo dosing in Abca4−/− mice with biochemical and electrophysiological endpoints\",\n      \"pmids\": [\"23211825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Metabolic efficacy of A1120 not assessed in this study\", \"Long-term safety and off-target effects not characterized\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Revealing RBP4 as an immunomodulatory adipokine: it was unclear how elevated RBP4 caused insulin resistance; adoptive transfer experiments demonstrated that RBP4 directly activates antigen-presenting cells via JNK to drive Th1 CD4+ T cell responses, adipose tissue inflammation, and systemic insulin resistance.\",\n      \"evidence\": \"RBP4-overexpressing transgenic mice, adoptive transfer of APCs into wild-type recipients, JNK inhibition, glucose/insulin tolerance tests\",\n      \"pmids\": [\"24606904\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the RBP4 receptor on APCs not established\", \"Whether retinol loading of RBP4 is required for APC activation not tested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrating TTR as a critical stabilizer of circulating RBP4 with metabolic consequences: TTR antisense knockdown reduced circulating RBP4 by 80–95% and improved whole-body insulin sensitivity by hyperinsulinemic clamp, establishing that TTR-dependent RBP4 stabilization is necessary for metabolic dysfunction.\",\n      \"evidence\": \"TTR antisense oligonucleotides in ob/ob and HFD mice, hyperinsulinemic-euglycemic clamp, tissue glucose uptake measurements\",\n      \"pmids\": [\"25524914\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether TTR knockdown benefits are entirely RBP4-dependent or partly due to loss of TTR itself\", \"Renal handling kinetics of free RBP4 not quantified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Linking human RBP4 mutations to congenital eye disease: dominant-negative RBP4 missense mutations were found to abolish retinol binding yet increase STRA6 affinity, competitively blocking retinol delivery and causing ocular malformations through a maternal-effect mechanism.\",\n      \"evidence\": \"Family-based mutation identification, retinol and STRA6 binding assays on recombinant mutant proteins\",\n      \"pmids\": [\"25910211\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of increased STRA6 affinity by mutant RBP4 not resolved\", \"Whether other tissues are affected in mutation carriers not fully assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Resolving the hepatocyte as the dominant source of circulating RBP4: liver-specific RBP4 knockout eliminated detectable circulating RBP4 despite intact adipose expression, definitively establishing hepatocytes—not adipocytes—as the principal systemic source.\",\n      \"evidence\": \"Hepatocyte-specific Cre-lox Rbp4 knockout mice, serum RBP4 measurement, adipose tissue expression analysis\",\n      \"pmids\": [\"27797907\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Paracrine role of adipocyte-derived RBP4 within adipose tissue not excluded\", \"Whether adipose RBP4 contributes to local inflammation independently of circulating pool not tested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Delineating the innate immune signaling pathway of RBP4: MyD88 knockout macrophages failed to respond to RBP4, establishing that RBP4 activates macrophages through MyD88-dependent MAPK/NF-κB signaling, and CTLA4-Ig blockade of costimulation in vivo reversed RBP4-driven insulin resistance.\",\n      \"evidence\": \"MyD88-KO macrophages, pathway inhibitors, CTLA4-Ig in RBP4-overexpressing mice, cytokine and metabolic readouts\",\n      \"pmids\": [\"26936962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The specific pattern-recognition receptor upstream of MyD88 that senses RBP4 is not identified\", \"Whether TLR4 or another TLR mediates the signal is unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating the essentiality of RBP4 for retinol mobilization and ocular integrity: Rbp4-knockout mice had undetectable serum retinol despite hepatic retinol accumulation and developed severe photoreceptor degeneration and choroidal atrophy.\",\n      \"evidence\": \"Rbp4-KO mice (C57BL/6), electroretinography, histology, serum/liver retinol quantification\",\n      \"pmids\": [\"26974396\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether dietary retinol supplementation can rescue ocular phenotype not tested\", \"Contribution of retinoic acid versus retinol signaling to the degeneration not dissected\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Establishing STRA6 as a cytokine receptor for RBP4 in cancer and muscle: RBP4–STRA6 interaction activates JAK2/STAT3 to maintain colon cancer stem cells and promote denervation-induced muscle atrophy; pharmacological RBP4 antagonist A1120 blocked muscle atrophy in vivo.\",\n      \"evidence\": \"STRA6/RBP4 knockdown in colon cancer cells and C2C12 myotubes, xenografts, denervation model, siRNA and inhibitor epistasis, A1120 rescue\",\n      \"pmids\": [\"28689994\", \"39031684\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether JAK2/STAT3 activation is direct (STRA6 kinase-independent scaffolding) or requires additional co-receptors\", \"Structural basis of STRA6 cytokine signaling versus transport function not resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Expanding the ligand repertoire of RBP4: high-resolution crystal structures revealed that plasma RBP4 binds fatty acids (palmitate, laurate) in its retinol-binding pocket, indicating RBP4 is not exclusively a retinol carrier.\",\n      \"evidence\": \"X-ray crystallography at 1.5 Å from plasma, urine, and amniotic fluid RBP4; mass spectrometry confirmation\",\n      \"pmids\": [\"29414511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of fatty acid binding on STRA6 or RBPR2 signaling not tested\", \"Relative occupancy of retinol versus fatty acid in vivo not determined\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that RBP4 regulates adipocyte lipolysis both directly and through macrophage-derived TNFα, linking RBP4-driven immune activation to lipid metabolic dysfunction.\",\n      \"evidence\": \"RBP4 treatment of human adipocytes, conditioned media from RBP4-activated macrophages, lipolysis and cytokine assays\",\n      \"pmids\": [\"32167208\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Receptor mediating direct lipolytic effect on adipocytes not identified\", \"In vivo lipolysis contribution of RBP4 not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealing a diabetic-specific post-translational mechanism: O-GlcNAcylation of RBPR2 by OGT under high-glucose conditions impairs hepatic RBP4 uptake, contributing to RBP4 overproduction; OGT silencing restored retinol homeostasis.\",\n      \"evidence\": \"Immunoprecipitation for O-GlcNAc-RBPR2, OGT silencing, CRBP1 transfection rescue in db/db and ob/ob mice and high-glucose hepatocytes\",\n      \"pmids\": [\"33065162\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific O-GlcNAcylation site(s) on RBPR2 not mapped\", \"Whether this mechanism operates in human diabetic liver not confirmed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying an exosomal RBP4 feedback loop in NAFLD: hepatocyte-derived exosomal RBP4 polarizes Kupffer cells to M1 via NOX2/ROS/NF-κB, which secrete TNFα that activates STAT3 in hepatocytes to further upregulate RBP4, establishing a self-amplifying inflammatory circuit.\",\n      \"evidence\": \"Serum exosome characterization, Kupffer cell polarization assays, NOX2/NF-κB inhibition, TNFα treatment, in vivo RBP4 injection in HFD mice\",\n      \"pmids\": [\"36572267\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether exosomal versus free RBP4 has distinct receptor engagement not compared\", \"Feedback loop not validated by genetic interruption in vivo\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the cell-surface receptor mediating RBP4's activation of antigen-presenting cells and macrophages (upstream of MyD88) remains unknown, and the structural basis for STRA6's dual function as retinol transporter and cytokine receptor has not been determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No receptor for RBP4 on macrophages/APCs identified\", \"No structural model of STRA6 in signaling versus transport mode\", \"Relative physiological importance of retinol-dependent versus retinol-independent RBP4 signaling not quantified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 5, 6, 14]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [2, 3, 7, 8, 9, 10]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [4, 6, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 3, 7, 8, 9, 19, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [2, 3, 10, 13]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [0, 5, 14]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [5, 7, 13]}\n    ],\n    \"complexes\": [\n      \"RBP4–TTR complex\"\n    ],\n    \"partners\": [\n      \"TTR\",\n      \"STRA6\",\n      \"RBPR2\",\n      \"JAK2\",\n      \"STAT3\",\n      \"MYD88\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}